...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith University

I had another look at the Zenith AGM presentation.

There are a lot of very promising developments and some very high profile partners. Great news.

The science seems to be in the early stages in terms of trials but results look good.

My guess is that Zenith will remain Zenith University for many years before, or if ever, it becomes Zenith Biotech Successful Business.

I don't see any evidence of biotech investment bankers swirling about. I don't see and drive or motivation to make this a business and investment. Don talked about liquidity over the years but never delivered. The CEO, researchers and management team are all well paid so not in a rush. From reading the profiles of the team they seem to be very qualified managers but they don't seem to be and have shown no evidence of being business entrepreneurs.

There does not seem to be any evidence of a business strategy. Perhaps the CEO has a team working independently on this? Hope so!

I get the impression they are comfortably sitting back waiting for a BP to make a big offer. Of course, I know nothing. So this is just a frustrated shareholder's opinion.

IMHO this company needs an attitude shift. Such exciting potential but no drive!

GLTA, we'll need it.

Toinv

Share
New Message
Please login to post a reply